This inventor holds 6 USPTO granted patents and 3 published patent applications and 5 EPO patents. Top assignees: Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften E. V. , Technical University of Darmstadt. Active years: 2014-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- München, DE (2014)
- Munich, DE (2016 - 2019)
- Reinheim, DE (2023)
Company Filing History:
6 out of 1,335 
1 out of 37 
Years Active: 2014-2023
Title: Felix Hausch: Innovator in Psychiatric Treatment
Introduction
Felix Hausch is a prominent inventor based in Munich, Germany. He has made significant contributions to the field of psychiatric treatment through his innovative research and development of novel compounds. With a total of 6 patents, Hausch has focused on creating solutions that address various psychiatric and neurodegenerative disorders.
Latest Patents
Hausch's latest patents include groundbreaking work on high affinity macrocyclic FKB51-inhibitors for the treatment of psychiatric disorders. These inhibitors enable the selective inhibition of FK506-binding proteins (FKBPs), which are crucial in the management of psychiatric disorders, metabolic disorders, pain diseases, and cancers. Another notable patent involves selective FKBP51 ligands, which are designed for the prophylaxis and treatment of psychiatric disorders and neurodegenerative diseases. These compounds, along with their pharmaceutically acceptable salts and compositions, represent a significant advancement in therapeutic options for patients.
Career Highlights
Throughout his career, Felix Hausch has been associated with esteemed institutions such as the Max Planck Society for the Advancement of Science and Technische Universität Darmstadt. His work in these organizations has allowed him to push the boundaries of research in psychiatric treatment and contribute to the scientific community.
Collaborations
Hausch has collaborated with notable colleagues, including Steffen Gaali and Alexander Kirschner. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to the development of effective therapeutic solutions.
Conclusion
Felix Hausch's contributions to the field of psychiatric treatment through his innovative patents and collaborations highlight his commitment to improving mental health care. His work continues to pave the way for new therapeutic options that can significantly impact the lives of individuals suffering from psychiatric disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile